Literature DB >> 26027578

Recent Advances and Strategies in Tumor Vasculature Targeted Nano-Drug Delivery Systems.

Man Ying, Guanyu Chen, Weiyue Lu1.   

Abstract

In recent decades, targeted nano-drug delivery systems have attracted extensive attention in cancer therapy for their efficient drug delivery and tumor site specificity. Tumor vasculature, including angiogenesis and vasculogenic mimicry is associated tightly with tumor growth, progression and metastasis. Therefore, nano-drug delivery systems targeting tumor vasculature are becoming a promising approach for tumor treatment. As complicated mechanisms and various factors are involved in the tumor vasculature, different ligands modified on the surface of nanocarriers acquire active targeting through binding to the receptors over-expressed by cancer cells or angiogenic endothelial cells. In this review, the tumor vasculature characteristics are briefly described and the recent advances and potential strategies in tumor vasculature targeted nano-drug delivery systems are introduced.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26027578     DOI: 10.2174/1381612821666150531163047

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  3 in total

Review 1.  Theoretical and Practical Principles on Nanoethics: A Narrative Review Article.

Authors:  Saeed Biroudian; Mahmoud Abbasi; Mehrzad Kiani
Journal:  Iran J Public Health       Date:  2019-10       Impact factor: 1.429

2.  Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.

Authors:  Dan Huang; Shuang Zhang; Ting Zhong; Wei Ren; Xin Yao; Yang Guo; Xiao-Chuan Duan; Yi-Fan Yin; Shu-Shi Zhang; Xuan Zhang
Journal:  Oncotarget       Date:  2016-07-12

Review 3.  Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.

Authors:  Ana Cavaco; Maryam Rezaei; Stephan Niland; Johannes A Eble
Journal:  Int J Mol Sci       Date:  2017-11-07       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.